4.7 Article

Virus-like particles produced in Saccharomyces cerevisiae elicit protective immunity against Coxsackievirus A16 in mice

Related references

Note: Only part of the references are listed.
Article Biotechnology & Applied Microbiology

Progress on the research and development of inactivated EV71 whole-virus vaccines

Zheng-Lun Liang et al.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)

Editorial Material Pediatrics

Picture of the Month

Aaron M. Secrest et al.

JAMA PEDIATRICS (2013)

Article Virology

A Neonatal Mouse Model of Coxsackievirus A16 for Vaccine Evaluation

Qunying Mao et al.

JOURNAL OF VIROLOGY (2012)

Article Multidisciplinary Sciences

Immunological and Biochemical Characterization of Coxsackie Virus A16 Viral Particles

Pele Chong et al.

PLOS ONE (2012)

Review Immunology

Virus-like particles in vaccine development

Antonio Roldao et al.

EXPERT REVIEW OF VACCINES (2010)

Review Infectious Diseases

Virology, epidemiology, pathogenesis, and control of enterovirus 71

Tom Solomon et al.

LANCET INFECTIOUS DISEASES (2010)

Article Immunology

Insect baculoviruses strongly potentiate adaptive immune responses by inducing type IIFN

Sandra Hervas-Stubbs et al.

JOURNAL OF IMMUNOLOGY (2007)

Article Immunology

Fatal coxsackievirus A16 infection

CY Wang et al.

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2004)

Article Biochemistry & Molecular Biology

Assembly of human severe acute respiratory syndrome coronavirus-like particles

Y Ho et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)

Article Immunology

Enterovirus 71 outbreaks, Taiwan: Occurrence and recognition

TY Lin et al.

EMERGING INFECTIOUS DISEASES (2003)